Get started
Minerva Neurosciences, IncMinerva Neurosciences, IncMinerva Neurosciences, Inc

Minerva Neurosciences, Inc

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

NERV chart

Key stats

Market capitalization
‪16.92 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.65USD
Net income
‪−30.01 M‬USD
Revenue
—
Shares float
‪5.44 M‬
Beta (1Y)
2.14

About Minerva Neurosciences, Inc

Sector
Health Technology
CEO
Rémy Henri Luthringer
Headquarters
Burlington
Website
minervaneurosciences.com
Employees (FY)
9
Founded
2007
ISIN
US6033802058
FIGI
BBG0067S9Z73
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NERV is 2.50 USD — it has increased by 3.31% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Minerva Neurosciences, Inc stocks are traded under the ticker NERV.
Minerva Neurosciences, Inc is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Minerva Neurosciences, Inc has a max estimate of 11.00 USD and a min estimate of 11.00 USD.
NERV earnings for the last quarter are −1.03 USD whereas the estimation was −0.77 USD which accounts for −33.77% surprise. Estimated earnings for the next quarter are −0.88 USD. See more details about Minerva Neurosciences, Inc earnings.
Minerva Neurosciences, Inc revenue for the last quarter amounts to 0 USD despite the estimated figure of ‪333.33 K‬ USD. In the next quarter revenue is expected to reach ‪333.33 K‬ USD.
Yes, you can track Minerva Neurosciences, Inc financials in yearly and quarterly reports right on TradingView.
Like other stocks, NERV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Minerva Neurosciences, Inc stock right from TradingView charts — choose your broker and connect to your account.
NERV reached its all-time high on Jun 2, 2016 with the price of 126.72 USD, and its all-time low was 1.26 USD and was reached on Dec 29, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 9.00 employees. See our rating of the largest employees — is Minerva Neurosciences, Inc on this list?